Daiichi Sankyo submits NDA for Lymphoma treatment Valemetostat in Japan

Tokyo: Daiichi Sankyo Company, Limited has announced that it has submitted a New Drug Application (NDA) to Japan’s Ministry of Health, Labour and Welfare (MHLW) for valemetostat, a …
( read original story …)